Express Scripts to lower generic costs through Walgreens Boots Alliance Development

ST. LOUIS — Express Scripts, through its wholly-owned subsidiary Innovative Product Alignment, on Thursday announced it will participate in the Walgreens Boots Alliance Development group purchasing organization.

"The agreement between Innovative Product Alignment and WBAD will improve supply chain efficiency and advance our ability to help reduce generic prescription drug prices for patients," stated Tim Wentworth, president and CEO, Express Scripts. "Our independent model gives us the flexibility to partner with companies like WBAD to make medicine more affordable and accessible. Econdisc is already extremely competitive today. By gaining access to WBAD through Innovative, we will be better positioned for the future."

In addition, Econdisc Contracting Solutions, a group purchasing organization that contracts with manufacturers to source generic pharmaceuticals on behalf of its participants, will have access to WBAD's sourcing efforts through an arrangement between Econdisc and Innovative Product Alignment. These two organizations will immediately begin developing a transition plan to maximize supply chain efficiencies.

WBAD, based in Bern, Switzerland, is a global group purchasing organization that sources and contracts generic pharmaceuticals on behalf of its members.  With Innovative as a member, WBAD will continue its ongoing efforts to reduce complexity in the global supply chain, both on behalf of its members as well as its manufacturing partners, in order to keep costs lower for patients and clients.


Login or Register to post a comment.